If You Test Positive for COVID-19, Get Treatment Right Away

Translate to Spanish or other 102 languages!

For many people, the sooner you act on your COVID-19 symptoms, the better! If you test positive — and are more likely to get very sick from COVID-19 — treatments are available to reduce your chances of severe illness.Image for illustration purposes
For many people, the sooner you act on your COVID-19 symptoms, the better! If you test positive — and are more likely to get very sick from COVID-19 — treatments are available to reduce your chances of severe illness.Image for illustration purposes

Mega Doctor News

- Advertisement -

MEDICARE – For many people, the sooner you act on your COVID-19 symptoms, the better! If you test positive — and are more likely to get very sick from COVID-19 — treatments are available to reduce your chances of severe illness.

Here’s what you need to know:

  • Don’t delay — get tested as soon as possible after your symptoms start. Treatment must be started within days after you first develop symptoms to be effective.
  • If you test positive, talk to your doctor or healthcare provider right away to find out if treatment is right for you, even if your symptoms are mild. There are multiple options for treating COVID-19 at home or in an outpatient setting.

COVID-19 Treatments

- Advertisement -

If you’re symptomatic, you may also want to consider using the Test to Treat program. With thousands of locations nationwide, it can provide faster, easier access to lifesaving COVID-19 treatments. If you test positive, you can see a healthcare provider, and if eligible, get a prescription for an oral COVID-19 treatment and have that prescription filled — all at one location.

Source: Medicare.gov

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.

DHR Health Burn Surgeon Urges Public to Avoid Preventable Risks

Many of the most serious burn and trauma injuries can be prevented by avoiding unnecessary risks, according to Dr. R. Dewayne Edwards, chief burn surgeon, surgical critical care and trauma surgeon at DHR Health, who said public awareness and timely medical care remain essential to improving patient outcomes.
- Advertisement -